PGGM Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
PGGM Investments's MRNA Position: Q3 2023 in Review
PGGM Investments sold out of Moderna (MRNA) in Q3 2023, closing a stake of 14,133 shares — an estimated $1.72M sold.
PGGM Investments first reported a position in MRNA in Q3 2021 and held it in 7 quarters. The position peaked at $10.9M in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.
- PGGM Investments reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
- PGGM Investments sold 14,133 Moderna shares in Q3 2023, an estimated $1.72M.
- PGGM Investments first reported a position in Moderna in Q3 2021 and held it in 7 quarters.
- PGGM Investments's Moderna position peaked at $10.9M in Q1 2023.
- 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.
Based on PGGM Investments's 13F filing for Q3 2023, filed 8 Nov 2023.